Suppr超能文献

[嫌色性肾细胞癌:42例临床病理研究及免疫表型分析]

[Chromophobe renal cell carcinoma: a clinicopathologic study and immunophenotypes of 42 cases].

作者信息

Zhang Wei, Yu Wen-juan, Jiang Yan-xia, Li Yu-jun, Han Fang, Liu Yan, Han Zeng-lei

机构信息

Department of Pathology, 401 Hospital of PLA, Qingdao 266071, China.

出版信息

Zhonghua Bing Li Xue Za Zhi. 2012 Feb;41(2):76-80.

Abstract

OBJECTIVE

To study the clinicopathologic features, immunohistochemical profiles and prognosis of chromophobe renal cell carcinoma (ChRCC).

METHODS

Forty-two cases of ChRCC were retrieved from the archival files of the Affiliated Hospital of Qingdao University, 401 Hospital of PLA and Qingdao Municipal Hospital from 2003 to 2011. The clinical and pathologic features of the tumors were reviewed. Hale colloidal iron staining was performed and EnVision immunohistochemistry was used to detect the expression of a series of immunologic markers. Forty cases of clear cell renal cell carcinoma and 10 cases of renal oncocytoma were selected as controls.

RESULTS

The patients included 17 males and 25 females. The age of patients ranged from 39 years to 78 years (median age = 57 years). On gross examination, the tumors ranged from 2 cm to 19 cm in greatest dimension (mean size = 7.3 cm). Histologically, the tumors were mainly composed of solid sheets, acini or tubules of malignant cells. The tumor cells contained clear finely reticular ("chromophobe") and eosinophilic cytoplasm with perinuclear clearing. The nuclear outline was irregular and wrinkled. Nucleoli were inconspicuous and mitotic figures were barely seen. Hale colloidal iron stain was positive in all cases. Immunohistochemically, the tumor cells were variably positive for EMA (100%, 42/42), CK7 (95.2%, 40/42), Ksp-cad (92.9%, 39/42), CK18 (88.1%, 37/42), CD117 (61.9, 26/42), CD10 (31.0%, 13/42) and PAX2 (28.6%, 12/42). They were negative for vimentin, CA IX and TFE3. The follow-up period in 31 patients ranged from 2 to 77 months (average duration = 29 months). Three patients died of tumor metastasis 3, 8, 13 months respectively after the operation. Twenty-eight patients were still alive without evidence of tumor recurrence.

CONCLUSIONS

ChRCC predominantly occurs in middle-aged and elderly patients. It often carries a favorable prognosis. The presence of plant cell-like morphology, pale cells with uniform reticular microvesicular appearance and perinuclear clearing are characteristic histologic features. The diffuse positivity for Hale colloidal iron stain and EMA/CK7/Ksp-cadherin/CD117-positive immunoprofiles are also useful in differential diagnosis.

摘要

目的

研究嫌色性肾细胞癌(ChRCC)的临床病理特征、免疫组化谱及预后。

方法

从青岛大学附属医院、解放军401医院及青岛市立医院2003年至2011年的存档文件中检索出42例ChRCC病例。回顾肿瘤的临床和病理特征。进行Hale胶体铁染色,并采用EnVision免疫组化法检测一系列免疫标志物的表达。选取40例透明细胞肾细胞癌和10例肾嗜酸细胞瘤作为对照。

结果

患者包括17例男性和25例女性。患者年龄范围为39岁至78岁(中位年龄 = 57岁)。大体检查时,肿瘤最大径为2 cm至19 cm(平均大小 = 7.3 cm)。组织学上,肿瘤主要由恶性细胞的实性片块、腺泡或小管组成。肿瘤细胞含有透明的细网状(“嫌色性”)和嗜酸性细胞质,核周有透亮区。核轮廓不规则且有皱纹。核仁不明显,几乎未见有丝分裂象。所有病例Hale胶体铁染色均为阳性。免疫组化方面,肿瘤细胞对EMA(100%,42/42)、CK7(95.2%,40/42)、Ksp-cad(92.9%,39/42)、CK18(88.1%,37/42)、CD117(61.9%,26/42)、CD10(31.0%,13/42)和PAX2(28.6%,12/42)呈不同程度阳性。它们对波形蛋白、CA IX和TFE3呈阴性。31例患者的随访期为2至77个月(平均时长 = 29个月)。3例患者分别在术后3、8、13个月死于肿瘤转移。28例患者仍存活,无肿瘤复发迹象。

结论

ChRCC主要发生于中老年患者。其预后通常较好。具有植物细胞样形态、呈均匀网状微泡外观且核周有透亮区的淡染细胞是其特征性组织学表现。Hale胶体铁染色弥漫阳性以及EMA/CK7/Ksp-钙黏蛋白/CD117阳性免疫谱在鉴别诊断中也很有用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验